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Surgical site events (SSE), including surgical wound complications and surgical site infections, are a
major concern in patients undergoing general surgery operations. These increase the costs of care, and
can lead to prolonged hospital stay and need for further treatments, ultimately resulting in poor quality
of life. Negative pressure wound therapy (NPWT) has been recently reported as a preventive strategy to
avoid SSE, but little is known on the topic, and particularly in geriatric population.
Our primary aim was to assess the efﬁcacy of NPWT by means of a pocket device (PICO, Smith &
Nephew, London, UK) in preventing SSE compared with conventional dressings in patients undergoing
surgery with primary wound closure for breast and for colorectal diseases in our Unit. Our secondary
aims were to assess the efﬁcacy and safety of PICO in elderly patients, and to seek for differences between
breast and abdominal results.
All consecutive patients undergoing breast and colorectal surgery in our Unit between September 2012
and May 2014 were prospectively enrolled in this open label controlled study. Breast patients receiving
NPWT were assigned to group B1, those receiving conventional dressings were assigned to group B2.
Colorectal patients were assigned to group C1 (NPWT) and C2 (conventional dressings) in similar fashion.
Each group included 25 patients, and at least 10 (40%) patients aged over 65 years to allow sub-analyses.
NPWT signiﬁcantly reduced SSE in both breast and colorectal patients compared with controls. No
signiﬁcant differences were observed according to age. Similar beneﬁts were observed in breast and
colorectal patients.
Our results suggest that PICO is an effective tool to prevent SSE in patients undergoing general surgery,
irrespective of age. Its use is recommended in frail, elderly patients at risk of SSE.
© 2014 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.esiologists score; BMI, body
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Surgical site events (SSE) are responsible for increased
morbidity in patients undergoing general surgery, and can cause
prolonged length of stay in the hospital [1,2]. SSE have a detri-
mental effect on the costs of hospital care, with more than 1.5
billion dollars in excess cost in the United States [3]. Although
several risk factors for SSE have been described [2e4], the rates of
SSE remain disturbingly high, and the preventing strategies need to
be implemented [4,5] as well as surgical teams adherence to these
[5].
Negative Pressure Wound Therapy (NPWT) reduces the inci-
dence of SSE in patients at risk, as we recently reported in a pro-
spective study on Crohn's disease patients receiving NPWT with a
pocket, disposable device, the PICO (Smith & Nephew, London, UK)
G. Pellino et al. / International Journal of Surgery 12 (2014) S64eS68 S65[2]. The use of PICO for preventing SSE in patients undergoing
surgery with primary wound closure has been poorly investigated
as well as its effects in elderly patients.
The primary aim of our study was to evaluate the efﬁcacy of
PICO compared with conventional dressings in preventing SSE in
patients undergoing surgerywith primarywound closure for breast
and colorectal diseases. The secondary aims were: to assess the
efﬁcacy and safety of PICO in elderly patients; to seek for outcome
differences between breast and abdominal surgery.2. Material and methods
All patients scheduled for breast or colorectal surgery in our Unit
between September 2012 and May 2014 were considered for in-
clusion. This is an open-label, prospective, controlled trial.
Written informed consent was obtained by each patient. Pa-
tients undergoing breast surgery were assigned to either group B1
if they received NPWT with PICO or group B2 if they received
conventional dressings. Patients undergoing colorectal surgery
were similarly assigned to either group C1 (PICO) or group C2
(conventional dressings). Each group comprised 25 patients, of
whom 10 (40%) aged over 65 years. Each group included a
maximum of 12 patients with malignancies.
Patient selection, surgical procedures, wound closure as well as
application of NPWT with PICO and protocol of medication with
conventional dressings in controls were performed as previously
reported [2,6e19].
Brieﬂy, at the end of each procedure the wound edges were
approximated by means of running sub-cuticular suture with non-
absorbable stitches (3/0, polypropylene/polyethylene). In group B1
and C1, PICO was applied (automatically set at 80 mmHg). Gauzes
were changed when too wet or after 3 days for the follow-up; the
device was always removed on the postoperative day 7. In group B2
and C2 basic wound contact absorbent dressings were used,
removed sterilely for control after 48 h. On post-operative day 3,
gauzes were removed sterilely and wounds left exposed if no
complications occurred.
All patients received perioperative antibiotic prophylaxis
[2,6,10].2.1. Data of interest and follow-up protocol
Demographics, American Society of Anesthesiologists (ASA)
score, body mass index (BMI), comorbidities, concomitant medical
treatment, length of incision, length of surgical procedure, in-
hospital stay, and perioperative complications were collected.
SSE were evaluated on postoperative-day 3, 7 and 30. Nonin-
fectious and septic wound complications were classiﬁed according
to Centers for Disease Control and Prevention (CDC) criteria [2,6,20]
and Global ASEPSIS score [2,6,21], respectively. Sub-group analyses
were performed according to age.
After discharge, standard follow-up intervals for this study were
at 7, 15 and 30 days, subsequently every two weeks for 3 months.
Overall results of breast patients were compared with those of
colorectal patients.2.2. Statistical analysis
Results are expressed as mean ± SD, unless otherwise indicated.
Categorical datawere compared using 2-tailed Fisher's exact test or
Chi-squared test; continuous variables were compared using
ManneWhitney test. P < 0.05 was considered statistically
signiﬁcant.3. Results
Baseline and surgical characteristics of all included patients are
reported in Table 1. No differences were observed in mean age of
patients in both groups. Breast surgery patients were all females,
while 22 male and 28 female were included in colorectal groups
(p < 0.0001). BMI, comorbidities, and ASA did not signiﬁcantly
differ between groups, and between breast and colorectal surgery
patients. Mean operative time and mean wound length were
signiﬁcantly higher in patients undergoing colorectal surgery
(p < 0.0001 and p ¼ 0.003, respectively). No differences were
observed in baseline and surgical data between B1 and B2, and
between C1 and C2 patients (Table 1).
No perioperative deaths occurred, and major postoperative
complications were similar between groups.
Outcomes of surgery and wound assessment are depicted in
Table 2. Length of in-hospital stay did not differ between B1 and B2,
but was almost reduced by half in colorectal patients with PICO
compared with controls (C1 vs C2 7.1 ± 2.1vs 12 ± 3.5 days,
p ¼ 0.001). Colorectal patients had longer length of stay compared
with breast patients (p < 0.0001). Rates of seroma were similar
between B1 and B2 patients, while in colorectal patients thesewere
higher in controls (C1 vs C2 8% vs 40%, p ¼ 0.02).
SSE according to CDC criteria were signiﬁcantly lower in all
patients receiving PICO (B1 vs B2 p ¼ 0.04; C1 vs C2 p ¼ 0.008).
Similarly, ASEPSIS scores were lower with PICO (B1 vs B2 p ¼ 0.03;
C1 vs C2 p ¼ 0.01).
Sub-analyses of patients aged over 65 years showed that the
rates of seroma were similar between PICO and controls, and be-
tween breast and colorectal patients. Conversely, the rates of in-
fectious SSE were much lower with PICO, compared with younger
patients, irrespective of the type of surgery (B1 vs B2, 0% vs 50%,
p ¼ 0.003; C1 vs C2, 10% vs 60%, p ¼ 0.003; breast vs colorectal
p > 0.99).
4. Discussion
Our data support the use of NPWT with PICO as an effective
preventive measure against SSE in patients undergoing general
surgery. No differences should be expected between breast and
colorectal surgery, with similar beneﬁts. When considering elderly
patients, the results are even more apparent.
SSE signiﬁcantly affect quality of life of patients undergoing
general surgery, and increase the costs of hospital stay [1e6].
Strategies have been proposed aiming to reduce the rate of infec-
tious SSE, but adherence to these guidelines may be suboptimal [5].
This can be attributed to little understanding of SSE by surgeons,
despite infectious SSE are reported to account for almost 10% of in-
hospital infections [1,2].
It has been reported that several factors may predict higher risks
of developing SSE, potentially allowing a better patient selection,
aimed to obtain the ideal risk-beneﬁt balance and to limit the costs
due to inappropriate NPWT indication. Aiming to identify pre-
dictors of SSE, Hedrick et al. [22] retrospectively evaluated the
medical records of 18,403 patients undergoing colorectal surgery,
showing a rate of infectious SSE as high as 7.86%. By means of
multivariable logistic regression analysis, they identiﬁed several
predictors of infectious SSE (age, alcohol abuse, ASA classiﬁcation,
stoma closure, open approach, BMI, and haematocrit), and pro-
posed predictive normograms according to these ﬁndings [22]. We
would add another category of patients at risk, inﬂammatory bowel
disease patients. These patients may undergo surgery at any age
[14,18,19], they may need to undergo repeated procedures
[2,6,18,19,23e33], and may be operated on while receiving immu-
nodepressant medications [14,19,34e39], further increasing the
Table 1
Characteristics and surgical data of patients undergoing breast (B) or colorectal (C) surgery. Data are mean ± SD and n (%).
Variable Group B1
(n ¼ 25)
Group B2
(n ¼ 25)
P Group C1
(n ¼ 25)
Group C2
(n ¼ 25)
P B Vs C Pa
Age, years (patients < 65) 36.4 ± 11.4 38 ± 14.8 0.8 39 ± 10.1 38 ± 15.4 0.8 0.7
Age, years (overall) 49.7 ± 18.6 50.6 ± 17.6 0.8 52 ± 10.5 51.3 ± 19.2 0.9 0.8
Male 0 (0) 0 (0) >0.99 13 (52) 9 (36) 0.4 <0.0001
BMI, kg/m2 22.2 ± 2.7 22 ± 2.1 0.9 22.7 ± 6 21.2 ± 4.3 0.6 >0.99
Diabetes 5 (20) 4 (16) >0.99 4 (16) 5 (20) >0.99 >0.99
ASA score  2 4 (16) 3 (12) >0.99 3 (12) 3 (12) >0.99 >0.99
Duration of surgery, minutes 72.3 ± 7.9 75 ± 9.2 0.3 169 ± 81 190 ± 75 0.7 <0.0001
Wound length 9.3 ± 5.5 8 ± 3.4 0.08 11.6 ± 7.2 12.4 ± 7.7 >0.99 0.003
SD: standard deviation; ASA: American Society of Anesthesiologists; BMI: body mass index.
B1, C1: NPWT with PICO; B2, C2: conventional dressings.
Statistically signiﬁcant P values are in bold.
a Overall B vs C comparison.
Table 2
General and wound-related complications patients undergoing breast (B) or colorectal (C) surgery. Data are mean ± SD and n (%).
Surgical complications Group B1
(n ¼ 25)
Group B2
(n ¼ 25)
P Group C1
(n ¼ 25)
Group C2(n ¼ 25) P B Vs C Pa
Death 0 (0) 0 (0) >0.99 0 (0) 0 (0) >0.99 >0.99
Major complications 3 (12) 2 (8) >0.99 5 (20) 6 (24) >0.99 0.2
Hospital stay, days 2 ± 1.2 2 ± 0.5 0.8 7.1 ± 2.1 12 ± 3.5 0.001 <0.0001
Wound outcome
Seroma 1 (4) 5 (20) 0.1 2 (8) 10 (40) 0.02 0.2
Infectious SSE according to CDC criteria(2,6,20) 2 (8) 9 (36) 0.04 2 (8) 11 (44) 0.008 0.8
Global ASEPSIS score(2,6,21) 12 ± 3.2 18.2 ± 5.1 0.03 14.6 ± 4.7 25.3 ± 3.3 0.01 0.07
Patients > 65-year-of-age Group B1
(n ¼ 10)
Group B2
(n ¼ 10)
P Group A
(n ¼ 10)
Group B
(n ¼ 10)
P
Seroma 0 (0) 4 (40) 0.09 1 (10) 4 (40) 0.3 >0.99
Infectious SSE according to CDC criteria(2,6,20) 0 (0) 5 (50) 0.003 1 (10) 6 (60) 0.003 >0.99
SD: standard deviation; ASA: American Society of Anesthesiologists; BMI: body mass index; CDC: Centers for Disease Control and Prevention; SSE: Surgical Site Events.
B1, C1: NPWT with PICO; B2, C2: conventional dressings.
Statistically signiﬁcant P values are in bold.
a Overall B vs C comparison.
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response and genetic predisposition cannot be ruled out, consid-
ering the autoimmune aetiopathogenesis of the diseases as well as
the importance of genetic and epigenetic predisposing factors
[40e42], which may also increase the rate of cancer risk and need
for surgery for malignancies [43e53].
Concerning age at surgery, advanced age signiﬁcantly increased
the risk of SSE when compared with younger patients [22]. This
may be due to higher rates of comorbidities, drug intake, and
chronic disease, and should be posed into perspectivewhen dealing
with elderly patients candidate to general surgery.
Cima et al. [54] recently published the impact on the rates of SSE
of a speciﬁc preventing algorithm in a single Center, suggesting
that, by adopting scheduled perioperativemeasures, theywere able
to reduce overall infectious SSE from 9.8% to 4.0% within one year.
However, in the proposed algorithm, preventive NPWT is never
mentioned.
We recently suggested the effectiveness of PICO, a pocket,
disposable NPWT device in reducing SSE of patients at risk [2,6].
The cost of PICO is moderate, and its price may further be justiﬁed
by the excess costs due to potential wound-related complications.
Also, it avoids the cumbersomeness of conventional NPWT devices,
and is user-friendly [2,6]. PICO favors healing through stimulation
of angiogenesis and granulation tissue formation [55], in a “sealed”
wound.
We showed that PICO can be safely delivered to patients un-
dergoing general surgery, and prevents SSE over closed incisions.
Moreover, elderly patients, who are known to be at higher risk of
SSE, would beneﬁt from its use. We would recommend preventive
NPWT with PICO in frail elderly patients and in those with at leastanother risk factor for SSE [22] undergoing general surgery, irre-
spective of the type of surgery.
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